Controversy and Consensus on Indications for Sperm DNA Fragmentation Testing in Male Infertility : A Global Survey, Current Guidelines, and Expert Recommendations
Copyright © 2023 Korean Society for Sexual Medicine and Andrology..
PURPOSE: Sperm DNA fragmentation (SDF) testing was recently added to the sixth edition of the World Health Organization laboratory manual for the examination and processing of human semen. Many conditions and risk factors have been associated with elevated SDF; therefore, it is important to identify the population of infertile men who might benefit from this test. The purpose of this study was to investigate global practices related to indications for SDF testing, compare the relevant professional society guideline recommendations, and provide expert recommendations.
MATERIALS AND METHODS: Clinicians managing male infertility were invited to take part in a global online survey on SDF clinical practices. This was conducted following the CHERRIES checklist criteria. The responses were compared to professional society guideline recommendations related to SDF and the appropriate available evidence. Expert recommendations on indications for SDF testing were then formulated, and the Delphi method was used to reach consensus.
RESULTS: The survey was completed by 436 experts from 55 countries. Almost 75% of respondents test for SDF in all or some men with unexplained or idiopathic infertility, 39% order it routinely in the work-up of recurrent pregnancy loss (RPL), and 62.2% investigate SDF in smokers. While 47% of reproductive urologists test SDF to support the decision for varicocele repair surgery when conventional semen parameters are normal, significantly fewer general urologists (23%; p=0.008) do the same. Nearly 70% would assess SDF before assisted reproductive technologies (ART), either always or for certain conditions. Recurrent ART failure is a common indication for SDF testing. Very few society recommendations were found regarding SDF testing.
CONCLUSIONS: This article presents the largest global survey on the indications for SDF testing in infertile men, and demonstrates diverse practices. Furthermore, it highlights the paucity of professional society guideline recommendations. Expert recommendations are proposed to help guide clinicians.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
The world journal of men's health - 41(2023), 3 vom: 20. Juli, Seite 575-602 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
DNA fragmentation |
---|
Anmerkungen: |
Date Revised 20.09.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.5534/wjmh.220282 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356223612 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356223612 | ||
003 | DE-627 | ||
005 | 20231226070017.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5534/wjmh.220282 |2 doi | |
028 | 5 | 2 | |a pubmed24n1187.xml |
035 | |a (DE-627)NLM356223612 | ||
035 | |a (NLM)37118960 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Agarwal, Ashok |e verfasserin |4 aut | |
245 | 1 | 0 | |a Controversy and Consensus on Indications for Sperm DNA Fragmentation Testing in Male Infertility |b A Global Survey, Current Guidelines, and Expert Recommendations |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2023 Korean Society for Sexual Medicine and Andrology. | ||
520 | |a PURPOSE: Sperm DNA fragmentation (SDF) testing was recently added to the sixth edition of the World Health Organization laboratory manual for the examination and processing of human semen. Many conditions and risk factors have been associated with elevated SDF; therefore, it is important to identify the population of infertile men who might benefit from this test. The purpose of this study was to investigate global practices related to indications for SDF testing, compare the relevant professional society guideline recommendations, and provide expert recommendations | ||
520 | |a MATERIALS AND METHODS: Clinicians managing male infertility were invited to take part in a global online survey on SDF clinical practices. This was conducted following the CHERRIES checklist criteria. The responses were compared to professional society guideline recommendations related to SDF and the appropriate available evidence. Expert recommendations on indications for SDF testing were then formulated, and the Delphi method was used to reach consensus | ||
520 | |a RESULTS: The survey was completed by 436 experts from 55 countries. Almost 75% of respondents test for SDF in all or some men with unexplained or idiopathic infertility, 39% order it routinely in the work-up of recurrent pregnancy loss (RPL), and 62.2% investigate SDF in smokers. While 47% of reproductive urologists test SDF to support the decision for varicocele repair surgery when conventional semen parameters are normal, significantly fewer general urologists (23%; p=0.008) do the same. Nearly 70% would assess SDF before assisted reproductive technologies (ART), either always or for certain conditions. Recurrent ART failure is a common indication for SDF testing. Very few society recommendations were found regarding SDF testing | ||
520 | |a CONCLUSIONS: This article presents the largest global survey on the indications for SDF testing in infertile men, and demonstrates diverse practices. Furthermore, it highlights the paucity of professional society guideline recommendations. Expert recommendations are proposed to help guide clinicians | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a DNA fragmentation | |
650 | 4 | |a Delphi method | |
650 | 4 | |a Male infertility | |
650 | 4 | |a Practice guidelines | |
650 | 4 | |a Sperm | |
650 | 4 | |a Survey | |
700 | 1 | |a Farkouh, Ala'a |e verfasserin |4 aut | |
700 | 1 | |a Saleh, Ramadan |e verfasserin |4 aut | |
700 | 1 | |a Abdel-Meguid Hamoda, Taha Abo-Almagd |e verfasserin |4 aut | |
700 | 1 | |a Harraz, Ahmed M |e verfasserin |4 aut | |
700 | 1 | |a Kavoussi, Parviz |e verfasserin |4 aut | |
700 | 1 | |a Arafa, Mohamed |e verfasserin |4 aut | |
700 | 1 | |a Salvio, Gianmaria |e verfasserin |4 aut | |
700 | 1 | |a Rambhatla, Amarnath |e verfasserin |4 aut | |
700 | 1 | |a Toprak, Tuncay |e verfasserin |4 aut | |
700 | 1 | |a Gül, Murat |e verfasserin |4 aut | |
700 | 1 | |a Phuoc, Nguyen Ho Vinh |e verfasserin |4 aut | |
700 | 1 | |a Boitrelle, Florence |e verfasserin |4 aut | |
700 | 1 | |a Birowo, Ponco |e verfasserin |4 aut | |
700 | 1 | |a Ghayda, Ramy Abou |e verfasserin |4 aut | |
700 | 1 | |a Cannarella, Rossella |e verfasserin |4 aut | |
700 | 1 | |a Kuroda, Shinnosuke |e verfasserin |4 aut | |
700 | 1 | |a Durairajanayagam, Damayanthi |e verfasserin |4 aut | |
700 | 1 | |a Zini, Armand |e verfasserin |4 aut | |
700 | 1 | |a Wyns, Christine |e verfasserin |4 aut | |
700 | 1 | |a Sarikaya, Selcuk |e verfasserin |4 aut | |
700 | 1 | |a Tremellen, Kelton |e verfasserin |4 aut | |
700 | 1 | |a Mostafa, Taymour |e verfasserin |4 aut | |
700 | 1 | |a Sokolakis, Ioannis |e verfasserin |4 aut | |
700 | 1 | |a Evenson, Donald P |e verfasserin |4 aut | |
700 | 1 | |a Henkel, Ralf |e verfasserin |4 aut | |
700 | 1 | |a Zohdy, Wael |e verfasserin |4 aut | |
700 | 1 | |a Chung, Eric |e verfasserin |4 aut | |
700 | 1 | |a Ziouziou, Imad |e verfasserin |4 aut | |
700 | 1 | |a Falcone, Marco |e verfasserin |4 aut | |
700 | 1 | |a Russo, Giorgio I |e verfasserin |4 aut | |
700 | 1 | |a Al-Hashimi, Manaf |e verfasserin |4 aut | |
700 | 1 | |a Calogero, Aldo E |e verfasserin |4 aut | |
700 | 1 | |a Ko, Edmund |e verfasserin |4 aut | |
700 | 1 | |a Colpi, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Lewis, Sheena |e verfasserin |4 aut | |
700 | 1 | |a Serefoglu, Ege Can |e verfasserin |4 aut | |
700 | 1 | |a Bahar, Fahmi |e verfasserin |4 aut | |
700 | 1 | |a Martinez, Marlon |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Quang |e verfasserin |4 aut | |
700 | 1 | |a Ambar, Rafael F |e verfasserin |4 aut | |
700 | 1 | |a Bakircioglu, Mustafa Emre |e verfasserin |4 aut | |
700 | 1 | |a Kandil, Hussein |e verfasserin |4 aut | |
700 | 1 | |a Mogharabian, Nasser |e verfasserin |4 aut | |
700 | 1 | |a Sabbaghian, Marjan |e verfasserin |4 aut | |
700 | 1 | |a Taniguchi, Hisanori |e verfasserin |4 aut | |
700 | 1 | |a Tsujimura, Akira |e verfasserin |4 aut | |
700 | 1 | |a Sajadi, Hesamoddin |e verfasserin |4 aut | |
700 | 1 | |a Ibrahim, Wael |e verfasserin |4 aut | |
700 | 1 | |a Atmoko, Widi |e verfasserin |4 aut | |
700 | 1 | |a Vogiatzi, Paraskevi |e verfasserin |4 aut | |
700 | 1 | |a Gunes, Sezgin |e verfasserin |4 aut | |
700 | 1 | |a Sadighi Gilani, Mohammad Ali |e verfasserin |4 aut | |
700 | 1 | |a Roychoudhury, Shubhadeep |e verfasserin |4 aut | |
700 | 1 | |a Güngör, Nur Dokuzeylül |e verfasserin |4 aut | |
700 | 1 | |a Hakim, Lukman |e verfasserin |4 aut | |
700 | 1 | |a Adriansjah, Ricky |e verfasserin |4 aut | |
700 | 1 | |a Kothari, Priyank |e verfasserin |4 aut | |
700 | 1 | |a Jindal, Sunil |e verfasserin |4 aut | |
700 | 1 | |a Amar, Edouard |e verfasserin |4 aut | |
700 | 1 | |a Park, Hyun Jun |e verfasserin |4 aut | |
700 | 1 | |a Long, Tran Quang Tien |e verfasserin |4 aut | |
700 | 1 | |a Homa, Sheryl |e verfasserin |4 aut | |
700 | 1 | |a Karthikeyan, Vilvapathy Senguttuvan |e verfasserin |4 aut | |
700 | 1 | |a Zilaitiene, Birute |e verfasserin |4 aut | |
700 | 1 | |a Maldonado Rosas, Israel |e verfasserin |4 aut | |
700 | 1 | |a Marino, Angelo |e verfasserin |4 aut | |
700 | 1 | |a Pescatori, Edoardo |e verfasserin |4 aut | |
700 | 1 | |a Ozer, Cevahir |e verfasserin |4 aut | |
700 | 1 | |a Akhavizadegan, Hamed |e verfasserin |4 aut | |
700 | 1 | |a Garrido, Nicolas |e verfasserin |4 aut | |
700 | 1 | |a Busetto, Gian Maria |e verfasserin |4 aut | |
700 | 1 | |a Adamyan, Aram |e verfasserin |4 aut | |
700 | 1 | |a Al-Marhoon, Mohamed |e verfasserin |4 aut | |
700 | 1 | |a Elbardisi, Haitham |e verfasserin |4 aut | |
700 | 1 | |a Dolati, Parisa |e verfasserin |4 aut | |
700 | 1 | |a Darbandi, Mahsa |e verfasserin |4 aut | |
700 | 1 | |a Darbandi, Sara |e verfasserin |4 aut | |
700 | 1 | |a Balercia, Giancarlo |e verfasserin |4 aut | |
700 | 1 | |a Pinggera, Germar-Michael |e verfasserin |4 aut | |
700 | 1 | |a Micic, Sava |e verfasserin |4 aut | |
700 | 1 | |a Ho, Christopher Chee Kong |e verfasserin |4 aut | |
700 | 1 | |a Moussa, Mohamad |e verfasserin |4 aut | |
700 | 1 | |a Preto, Mirko |e verfasserin |4 aut | |
700 | 1 | |a Zenoaga-Barbăroșie, Cătălina |e verfasserin |4 aut | |
700 | 1 | |a Smith, Ryan P |e verfasserin |4 aut | |
700 | 1 | |a Kosgi, Raghavender |e verfasserin |4 aut | |
700 | 1 | |a de la Rosette, Jean |e verfasserin |4 aut | |
700 | 1 | |a El-Sakka, Ahmed I |e verfasserin |4 aut | |
700 | 1 | |a Abumelha, Saad Mohammed |e verfasserin |4 aut | |
700 | 1 | |a Mierzwa, Tiago Cesar |e verfasserin |4 aut | |
700 | 1 | |a Ong, Teng Aik |e verfasserin |4 aut | |
700 | 1 | |a Banihani, Saleem A |e verfasserin |4 aut | |
700 | 1 | |a Bowa, Kasonde |e verfasserin |4 aut | |
700 | 1 | |a Fukuhara, Shinichiro |e verfasserin |4 aut | |
700 | 1 | |a Boeri, Luca |e verfasserin |4 aut | |
700 | 1 | |a Danacıoğlu, Yavuz Onur |e verfasserin |4 aut | |
700 | 1 | |a Gokalp, Fatih |e verfasserin |4 aut | |
700 | 1 | |a Selim, Osama Mohamed |e verfasserin |4 aut | |
700 | 1 | |a Cho, Chak-Lam |e verfasserin |4 aut | |
700 | 0 | |a Global Andrology Forum |e verfasserin |4 aut | |
700 | 0 | |a et al |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The world journal of men's health |d 2012 |g 41(2023), 3 vom: 20. Juli, Seite 575-602 |w (DE-627)NLM226777995 |x 2287-4208 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2023 |g number:3 |g day:20 |g month:07 |g pages:575-602 |
856 | 4 | 0 | |u http://dx.doi.org/10.5534/wjmh.220282 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2023 |e 3 |b 20 |c 07 |h 575-602 |